Terhorst-Molawi, Dorothea
Fox, Lena
Siebenhaar, Frank
Metz, Martin
Maurer, Marcus http://orcid.org/0000-0002-4121-481X
Funding for this research was provided by:
Charité - Universitätsmedizin Berlin
Article History
Accepted: 24 January 2023
First Online: 22 February 2023
Declarations
:
: Open Access funding enabled and organized by Projekt DEAL. Intramural.
: DTM has received research funds and/or was advisor for Celldex, Moxie, Novartis and Sanofi. FS is or recently was a speaker and/or advisor for and/or has received research funding from Allakos, Blueprint, Celldex, CogentBio, Genentech, GSK, Novartis, Moxie, Sanofi/Regeneron, ThirdHarmonicBio and Uriach. MMe has received honoraria as a speaker and/or consultant for AbbVie, Amgen, ArgenX, AstraZeneca, Bayer, Celldex, Celgene, Escient, Galderma, Grünenthal, GSK, Menlo, Novartis, Pfizer, Pharvaris, Roche, Sanofi-Aventis, Teva, and Third Harmonic Bio. MMa is or recently was a speaker and/or advisor for and/or has received research funding from Allakos, Amgen, Aralez, ArgenX, AstraZeneca, Celldex, Centogene, CSL Behring, FAES, Genentech, GIInnovation, Gilead, Innate Pharma, Kyowa Kirin, Leo Pharma, Lilly, Menarini, Moxie, Novartis, Roche, Sanofi/Regeneron, Third HarmonicBio, UCB, and Uriach.
: Not applicable.
: Not applicable.
: Was provided by all coauthors.
: Not applicable.
: Not applicable.
: All authors developed the outline, DTM and LF prepared the first complete draft, all authors contributed to the finalization of the manuscript.